What Happens If Kidney Stones Are Left Untreated?

What Happens If Kidney Stones Are Left Untreated?: Kidney stones (urolithiasis) are common worldwide and especially prevalent in certain regions of India known as the stone belt of India. While many stones cause temporary pain and pass spontaneously, untreated stones can produce a cascade of events — obstruction, infection, inflammation and progressive loss of kidney tissue — that may culminate in chronic kidney disease (CKD), acute kidney injury (AKI), or even end-stage renal disease (ESRD).

This article explains, in clear clinical language, how untreated stones damage kidneys (the pathophysiology), what symptoms and signs to look for, the modern approach to diagnosis, current treatment options and up-to-date medical trends and evidence.

Introduction

Many patients view kidney stones as an episodic problem — a short, sharp bout of pain that ends once the stone passes. That partial picture misses the full risk. A stone that is left untreated does not simply disappear; instead it can become a persistent source of obstruction, infection, chronic inflammation and kidney damage. Understanding the biological steps by which a lodged stone evolves into compromised renal function helps clinicians and patients appreciate why timely diagnosis and appropriate management are essential.

In India, where climatic, dietary and socioeconomic factors concentrate stone disease in the so-called stone belt (Rajasthan, Gujarat, Punjab, Haryana, parts of Madhya Pradesh and western Uttar Pradesh), untreated stones are an important and preventable contributor to kidney damage. Regional studies confirm that stone disease in these areas is common and that calcium oxalate remains the most frequent composition in many districts.

How kidney damage actually happens — the pathophysiology explained

When thinking about how a stone damages the kidney, it helps to follow a simple sequence:

1. Formation and lodgement of the stone
   Stones form in the renal calyces or pelvis from crystallization of salts (calcium oxalate, calcium phosphate, uric acid, struvite, cystine). A migrating stone may lodge at narrow points — the pelvi-ureteric junction (PUJ), along the ureter, or at the ureterovesical junction (UVJ).
2. Obstruction of urine flow (post-renal obstruction)
   A lodged stone blocks the normal antegrade flow of urine. Urine accumulates above the obstruction, increasing intrapelvic and intrarenal pressure. This mechanical back-pressure is the pivotal early injury mechanism.
3. Increased hydrostatic pressure → decreased GFR
   Elevated hydrostatic pressure in Bowman’s space opposes filtration pressure and reduces glomerular filtration rate (GFR). If the obstruction is complete, GFR falls rapidly; if partial or intermittent, the fall is slower but progressive.
4. Compression, ischemia and tubular injury
   Increased interstitial pressure compresses renal vasculature and small vessels, causing relative ischemia. Ischemia and stasis injure tubular epithelial cells, reducing reabsorptive capacity and causing cellular death (necrosis and apoptosis) when prolonged.
5. Inflammation and fibrosis
   Injured cells release inflammatory mediators (cytokines, chemokines) that recruit immune cells. Chronic inflammation stimulates fibroblast activation and extracellular matrix deposition — i.e., interstitial fibrosis and tubular atrophy. Fibrosis is the main pathway to permanent loss of nephrons and irreversible decline in renal function.
6. Infection accelerates damage
   Stones, especially struvite (infection) stones, act as niduses for bacteria. Obstruction with infection impairs antibiotic delivery to the infected renal pelvis, increasing the risk of pyonephrosis and urosepsis. Infection amplifies inflammation and accelerates parenchymal destruction.
7. Bilateral disease or single-kidney obstruction is catastrophic
   A solitary functioning kidney obstructed by stone, or bilateral obstructing stones, can cause rapid kidney failure (oliguria/anuria) and metabolic derangements requiring urgent decompression and sometimes dialysis.

The net result: if obstruction and/or infection persist, functional nephron units are lost through ischemia, inflammation and fibrosis, and the kidney’s recovery potential diminishes with time. Experimental and clinical studies document that prolonged obstruction leads to cortical thinning, loss of renal mass and reduced recovery even after obstruction is relieved.

Clinical course and typical symptoms when stones are left untreated

Early / intermittent phase

• Flank pain or colic when the stone moves — intense, episodic, sometimes radiating to the groin.
• Dull flank ache or low-grade discomfort if the stone is stationary.
• Hematuria (blood in urine) – microscopic or visible.

Progressive / complicated phase (signals danger if left unattended)

• Persistent or worsening pain, sometimes diffuse abdominal discomfort.
• Recurrent or persistent fever suggesting infection; may be low-grade initially.
• Dysuria, frequency, urgency if the stone is lower in the tract or infection spreads.
• Reduced urine output, oliguria or anuria — medical emergency suggesting bilateral obstruction or obstruction in a solitary kidney.
• Systemic features (malaise, anorexia, weight loss) in chronic disease.
• Hypertension — chronic kidney injury may lead to secondary hypertension.
• Symptoms of uremia (nausea, vomiting, poor appetite, pruritus) in advanced or chronic renal failure.

Important clinical point: “silent obstruction” — many patients (particularly elderly and diabetic patients) may have minimal pain yet progressive hydronephrosis and renal damage. Because pain is not a reliable sole marker of severity, clinical vigilance and periodic evaluation of renal function are required.

Diagnostic pathway: what clinicians should do and why

A systematic diagnostic approach helps identify both the stone and its impact on renal function.

1. History and physical examination

• Onset, character and radiation of pain.
• Fever, urinary symptoms, urinary output.
• Previous stone history, family history, diet, fluid intake.
• Comorbidities: diabetes, hypertension, gout or metabolic syndrome.

2. Basic laboratory tests

• Serum creatinine and eGFR — assess kidney function baseline and progression.
• Electrolytes — obstruction and renal failure can cause hyperkalemia, acidosis.
• Complete blood count — leukocytosis suggests infection.
• Urine analysis — hematuria, pyuria, crystals.
• Urine culture — essential if infection suspected; guides antibiotic therapy.

3. Imaging

• Ultrasound (USG KUB) — good first test; detects hydronephrosis and larger stones, especially for follow-up in pregnancy or when radiation should be avoided.
• Non-contrast CT KUB (NCCT) — the gold standard for stone detection and assessing stone size, density and exact location. NCCT also helps plan intervention. EAU guidelines recommend NCCT for acute flank pain when available.
• Plain KUB X-ray — useful for radiopaque stones and follow-up after treatment.
• DTPA/MAG3 renal scan — nuclear medicine scan to quantify differential renal function and drainage; particularly important when considering whether a kidney is salvageable or non-functional.
• Contrast studies (IVU) are less commonly used now because NCCT provides superior information.

4. When to suspect complicated obstruction

• Rising serum creatinine, oliguria/anuria.
• Fever with obstruction → suspect infected obstruction (pyonephrosis) — requires urgent drainage.
• Single kidney or transplanted kidney — any obstruction is emergent.

Together, laboratory and imaging data guide urgency and the optimal intervention (urgent drainage vs definitive stone removal).

Treatment: staged and individualized

Management of stone disease depends on symptoms, stone size and location, presence of infection, and renal function. The overall goals are to relieve obstruction, eradicate infection, remove stone burden and preserve renal function.

A. Emergency measures (when obstruction or infection threatens kidney function)

• Urgent decompression — either retrograde ureteral stenting (double-J stent) or percutaneous nephrostomy (PCN) to drain the collecting system. Timely drainage saves life in obstructed, infected systems (pyonephrosis, urosepsis). Studies show early decompression reduces mortality and improves outcomes.
• Broad-spectrum intravenous antibiotics guided by blood/urine cultures — but antibiotics alone are insufficient when obstruction persists.
• Supportive care — fluid and electrolyte correction, vasopressors if septic shock develops, and renal replacement therapy (dialysis) when indicated.

B. Definitive stone removal

Once the emergency is controlled (infection controlled, drainage established), definitive treatment is planned:

• Ureteroscopy (URS) and Retrograde Intrarenal Surgery (RIRS) — flexible ureteroscopy with laser lithotripsy is ideal for ureteral and intrarenal stones up to certain sizes; it’s minimally invasive with fast recovery.
• Percutaneous Nephrolithotomy (PCNL) — preferred for large (>2 cm) renal stones or staghorn calculi. Mini and ultra-mini PCNL techniques reduce morbidity while maintaining efficacy.
• Shock Wave Lithotripsy (SWL) — non-invasive option for selected small to medium stones in favourable locations.
• Open or laparoscopic surgery — rare now but reserved for complex anatomy or failed minimally invasive attempts.

Choice of procedure considers stone burden, composition, anatomy, renal function and comorbidities. Modern approaches emphasise kidney-preserving, minimally invasive techniques.

C. When kidneys don’t recover

• If a kidney has lost function due to chronic obstruction and has minimal differential function on a DTPA/MAG3 scan, nephrectomy may be required, particularly if recurrent infections or pain persist.
• Long-term dialysis or renal transplantation is required for ESRD.

D. Prevention and metabolic evaluation

• After the acute event, a metabolic workup (24-hour urine collection, serum biochemistry, stone analysis) identifies correctable risk factors: hypercalciuria, hyperoxaluria, hypocitraturia, hyperuricosuria, low urine volume.
• Medical prophylaxis: thiazide diuretics for hypercalciuria, potassium citrate for hypocitraturia/alkalinization (uric acid stone prevention), allopurinol for hyperuricemia when indicated.
• Dietary strategies: adequate fluid intake (target urine output ~2–2.5 L/day), reduced salt and excessive animal protein, moderated oxalate intake, and appropriate dietary calcium.

Prevention reduces recurrence and long-term renal risk; persistently untreated stone formers have higher rates of CKD.

Evidence and current trends in management

1. Early imaging and early decompression: Contemporary guidelines endorse rapid use of NCCT for diagnosis and immediate imaging in cases with fever or a solitary kidney; urgent decompression is lifesaving in infected obstruction. These guideline-level recommendations are based on consistent evidence showing improved outcomes with prompt action.
2. Minimally invasive, nephron-sparing surgery: The evolution of flexible ureteroscopy, laser lithotripsy and mini-PCNL allows clinicians to remove complex stones while preserving renal tissue and reducing morbidity. These shifts have resulted in shorter hospital stays and faster recovery.
3. Recognition of stones as a CKD risk factor: Large epidemiologic studies (including the seminal work by Rule et al.) demonstrate that stone formers have a higher risk for sustained reductions in GFR and CKD over time, especially when interventions are delayed or recurrent infections occur. This encourages active follow-up and metabolic evaluation rather than simple reassurance.
4. Infection-related hazards: Recent literature continues to emphasise that infected obstructing stones (pyonephrosis) carry high risk of septic shock and death unless decompressed early — a clinical message especially relevant to areas where late presentation is common.
5. Regional focus — the Indian stone belt: Research from Rajasthan and neighbouring states documents a high burden of calcium oxalate stones and frequent delayed presentation in rural populations. These regional data underline the need for public health measures: hydration campaigns, community education, access to diagnostics and early referral pathways.

Real-world consequences of delayed or absent treatment

• Increased likelihood of renal scarring and permanent loss of function, especially after months to years of unresolved obstruction.
• Higher rate of infections and antibiotic resistance, since stones shelter bacteria from eradication.
• Greater chance of emergency presentations (anuria, urosepsis, pyonephrosis) necessitating urgent drainage and sometimes intensive care.
• Economic and social burden — repeated hospital visits, loss of productivity, cost of dialysis if progression to ESRD occurs.

These outcomes are preventable in many cases with early detection, appropriate emergency management and definitive stone removal, followed by prevention strategies.

Practical recommendations for clinicians and patients

For clinicians

• Maintain a low threshold for imaging (NCCT) when patients present with flank pain and risk factors.
• Always check renal function and order urine culture when infection is suspected.
• Treat obstructed, infected systems as emergencies — decompress first, then treat stones.
• Arrange metabolic evaluation and patient education after definitive treatment.

For patients (clear actionable points)

• Don’t ignore flank pain, recurrent urinary tract symptoms or visible blood in urine. Early evaluation can preserve kidney function.
• Stay adequately hydrated, especially in hot climates — aim for a urine output of roughly 2–2.5 L/day.
• Follow up after stone passage or treatment — stone analysis and urine tests guide prevention.
• Seek immediate care for fever with urinary symptoms — it can be a sign of dangerous infected obstruction.

Prevention at the population level (importance in the Indian stone belt)

In the stone belt regions, simple public-health measures could reduce the burden:

• Public education on hydration and diet.
• Community access to basic diagnostics (ultrasound, urine testing).
• Training primary-care providers to recognize red flags and refer early.
• Programs for water quality and salt reduction in diet where appropriate.

Such interventions could reduce late presentations and the downstream risk of CKD and ESRD in resource-limited settings.

Conclusion — the bottom line

Leaving kidney stones untreated is not merely delaying pain relief; it risks progressive, sometimes irreversible kidney injury — via mechanical obstruction, ischemia, inflammation, infection and fibrosis. In geographic areas with high disease burden, like India’s stone belt, delayed presentation and limited access to timely care amplify that risk. Modern urology provides effective and kidney-sparing interventions, but outcomes depend on early recognition, appropriate emergency action (decompression in infected obstruction), definitive stone removal and long-term preventive care.

Expert care at the Institute of Urology, Jaipur

For patients seeking comprehensive and timely care, the Institute of Urology, Jaipur provides an integrated setup — outpatient consultation, advanced diagnostics (ultrasound, NCCT, DTPA/MAG3 scans), laboratory services, emergency decompression (DJ stenting and PCN), endourology (RIRS, URS), PCNL (including mini-PCNL), and general surgical support — all under one roof. This multidisciplinary environment ensures rapid decision-making and continuity of care, which is crucial when obstruction or infection threatens renal function.

Dr. M. Roychowdhury and Dr. Rajan Bansal bring extensive experience in the management of stone disease and obstructive uropathy. Their practice focuses on early intervention, minimally invasive techniques and individualized prevention strategies to preserve renal function and prevent recurrence. Patients with complex stones, recurrent infections, or impaired renal function receive coordinated, evidence-based care designed to restore drainage, remove stone burden and minimize long-term renal damage.

Selected key references

1. Rule AD, Bergstralh EJ, Melton LJ 3rd, Li X, Weaver AL, Lieske JC. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(4):804–811. — important epidemiologic evidence linking stone disease to sustained reductions in renal function.
2. European Association of Urology (EAU) Guidelines on Urolithiasis. — contemporary diagnostic and treatment recommendations, including the role of NCCT and urgent imaging for fever/solitary kidney.
3. Yaxley J et al. Obstructive uropathy — acute and chronic medical perspectives. BMJ (Open Access review). 2023. — pathophysiology of obstruction and clinical outcomes.
4. Bhat A et al. Spectrum of urinary stone composition in Northwestern Rajasthan. Indian Journal of Urology. 2018. — regional data confirming stone composition patterns in India’s stone belt.
5. Del Giudice F et al. Characteristics of sepsis due to urinary stones and importance of early decompression. Applied Sciences. 2022. — evidence that early surgical decompression lowers mortality in sepsis from obstructed stones.

(Note: the references above represent key studies and guideline documents; authors and journals are cited for clinicians to explore the primary literature.)